Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
Ajouter des filtres








Gamme d'année
1.
Braz. j. med. biol. res ; 42(9): 824-830, Sept. 2009. ilus, graf
Article Dans Anglais | LILACS | ID: lil-524318

Résumé

The generation of bradykinin (BK; Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg) in blood and kallidin (Lys-BK) in tissues by the action of the kallikrein-kinin system has received little attention in non-mammalian vertebrates. In mammals, kallidin can be generated by the coronary endothelium and myocytes in response to ischemia, mediating cardioprotective events. The plasma of birds lacks two key components of the kallikrein-kinin system: the low molecular weight kininogen and a prekallikrein activator analogous to mammalian factor XII, but treatment with bovine plasma kallikrein generates ornitho-kinin [Thr6,Leu8]-BK. The possible cardioprotective effect of ornitho-kinin infusion was investigated in an anesthetized, open-chest chicken model of acute coronary occlusion. A branch of the left main coronary artery was reversibly ligated to produce ischemia followed by reperfusion, after which the degree of myocardial necrosis (infarct size as a percent of area at risk) was assessed by tetrazolium staining. The iv injection of a low dose of ornitho-kinin (4 µg/kg) reduced mean arterial pressure from 88 ± 12 to 42 ± 7 mmHg and increased heart rate from 335 ± 38 to 402 ± 45 bpm (N = 5). The size of the infarct was reduced by pretreatment with ornitho-kinin (500 µg/kg infused over a period of 5 min) from 35 ± 3 to 10 ± 2 percent of the area at risk. These results suggest that the physiological role of the kallikrein-kinin system is preserved in this animal model in spite of the absence of two key components, i.e., low molecular weight kininogen and factor XII.


Sujets)
Animaux , Bradykinine/analogues et dérivés , Cardiotoniques/usage thérapeutique , Kinines/effets des médicaments et des substances chimiques , Infarctus du myocarde/prévention et contrôle , Vasodilatateurs/usage thérapeutique , Maladie aigüe , Inhibiteurs de l'enzyme de conversion de l'angiotensine/pharmacologie , Pression sanguine/effets des médicaments et des substances chimiques , Bradykinine/usage thérapeutique , Poulets , Captopril/pharmacologie , Modèles animaux de maladie humaine , Préconditionnement ischémique myocardique , Kinines/sang , Kinines/physiologie , Infarctus du myocarde/métabolisme , Infarctus du myocarde/anatomopathologie , Soins préopératoires , Résistance vasculaire/effets des médicaments et des substances chimiques
2.
Braz. j. med. biol. res ; 41(7): 557-562, July 2008. ilus, graf
Article Dans Anglais | LILACS | ID: lil-489517

Résumé

It is well known that the ventrolateral medulla contains neurons involved in the tonic and reflex control of the cardiovascular system. Two regions within the ventrolateral medulla were initially identified: the rostral ventrolateral medulla (RVLM) and the caudal ventrolateral medulla (CVLM). Activation of the RVLM raises arterial blood pressure and sympathetic nerve activity, and activation of the CVLM causes opposite effects. The RVLM premotor neurons project directly to sympathetic preganglionic neurons and are involved in the maintenance of resting sympathetic vasomotor tone. A significant proportion of tonic activity in the RVLM sympathetic premotor neurons is driven by neurons located in a third region of the ventrolateral medulla denominated caudal pressor area (CPA). The CPA is a pressor region located at the extreme caudal part of the ventrolateral medulla that appears to have an important role controlling the activity of RVLM neurons. In this brief review, we will address the importance of the ventrolateral medulla neurons for the generation of resting sympathetic tone related to arterial blood pressure control focusing on two regions, the RVLM and the CPA.


Sujets)
Animaux , Pression sanguine/physiologie , Moelle allongée/physiologie , Neurones/physiologie , Système vasomoteur/physiologie , Agents GABA/pharmacologie , Microinjections , Moelle allongée/effets des médicaments et des substances chimiques , Inhibition nerveuse/physiologie , Système nerveux sympathique/physiologie , Acide gamma-amino-butyrique/pharmacologie
SÉLECTION CITATIONS
Détails de la recherche